- Fund Type: FCP
- Objective: Income Equity
- Asset Class: Equity
- Geographic Focus: Global
BlackRock Global Investment Series - Global Equity Income Portfolio
+ Add to WatchlistBRGEIA2:LX
12.48 USD 0.02 0.16%As of 00:59:30 ET on 05/21/2013.
Snapshot for BlackRock Global Investment Series - Global Equity Income Portfolio (BRGEIA2)
| Year To Date: | +12.77% | 3-Month: | +8.13% | 3-Year: | - | 52-Week Range: | 10.02 - 12.50 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +4.17% | 1-Year: | +24.78% | 5-Year: | - | Beta vs LUXXX: | 0.70 |
Fund Profile & Information for BRGEIA2
BlackRock Global Investment Series - Global Equity Income Portfolio is an FCP incorporated in Luxembourg. The Fund's objective is to produce a sustainable yield from a diversified portfolio of global equity securities. The Portfolio seeks to outperform in terms of dividend yield the MSCI All Country World Index.
| Inception Date: | 08-25-2011 | Telephone: | Not Disclosed |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.blackrockinternational.com | ||
Fundamentals for BRGEIA2
| NAV | (on 2013-05-21) 12.48 |
|---|---|
| Assets (M) | (on 2013-05-21) 188.07 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for BRGEIA2
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Monthly |
| Last Dividend Net | (on 2013-04-22) 0.03 |
| Dividend Yield (ttm) | 2.88 |
Fees & Expenses for BRGEIA2
| Front Load | - |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.60 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for BRGEIA2
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Institutional Cash Series PLC | 5,715,962 | 5,715,962 | 3.469% |
| Roche Holding AG | 20,746 | 5,163,954 | 3.134% |
| Pfizer Inc | 173,814 | 5,143,156 | 3.122% |
| Imperial Tobacco Group PLC | 139,700 | 5,003,085 | 3.037% |
| Sanofi | 46,058 | 5,000,785 | 3.035% |
| Novartis AG | 62,386 | 4,603,700 | 2.794% |
| Microsoft Corp | 138,034 | 4,484,725 | 2.722% |
| Coca-Cola Co/The | 106,182 | 4,466,015 | 2.711% |
| Merck & Co Inc | 90,504 | 4,320,661 | 2.622% |
| GlaxoSmithKline PLC | 164,502 | 4,237,415 | 2.572% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page